- Home
- IXHL vs QTTB Comparison
IXHL vs QTTB Comparison
Compare IXHL & QTTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IXHL
- QTTB
- Stock Information
- Founded
- IXHL 2001
- QTTB 2015
- Country
- IXHL Australia
- QTTB United States
- Employees
- IXHL N/A
- QTTB N/A
- Industry
- IXHL
- QTTB Biotechnology: Pharmaceutical Preparations
- Sector
- IXHL
- QTTB Health Care
- Exchange
- IXHL Nasdaq
- QTTB Nasdaq
- Market Cap
- IXHL 13.2M
- QTTB N/A
- IPO Year
- IXHL N/A
- QTTB N/A
- Fundamental
- Price
- IXHL $0.68
- QTTB $1.50
- Analyst Decision
- IXHL
- QTTB Hold
- Analyst Count
- IXHL 0
- QTTB 8
- Target Price
- IXHL N/A
- QTTB $24.00
- AVG Volume (30 Days)
- IXHL 61.2K
- QTTB 145.8K
- Earning Date
- IXHL 05-14-2025
- QTTB 03-11-2025
- Dividend Yield
- IXHL N/A
- QTTB N/A
- EPS Growth
- IXHL N/A
- QTTB N/A
- EPS
- IXHL N/A
- QTTB N/A
- Revenue
- IXHL $98,000.00
- QTTB N/A
- Revenue This Year
- IXHL $3,817.06
- QTTB N/A
- Revenue Next Year
- IXHL $66.67
- QTTB N/A
- P/E Ratio
- IXHL N/A
- QTTB N/A
- Revenue Growth
- IXHL N/A
- QTTB N/A
- 52 Week Low
- IXHL $0.64
- QTTB $1.48
- 52 Week High
- IXHL $3.55
- QTTB $53.79
- Technical
- Relative Strength Index (RSI)
- IXHL 22.72
- QTTB 24.81
- Support Level
- IXHL $0.73
- QTTB $1.80
- Resistance Level
- IXHL $1.18
- QTTB $2.20
- Average True Range (ATR)
- IXHL 0.08
- QTTB 0.18
- MACD
- IXHL 0.02
- QTTB 0.02
- Stochastic Oscillator
- IXHL 0.46
- QTTB 2.47
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.